Shares of Theratechnologies Inc. (TSE:TH – Get Free Report) crossed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of C$2.04 and traded as high as C$2.24. Theratechnologies shares last traded at C$2.23, with a volume of 55,925 shares traded.
Analyst Ratings Changes
Separately, Cantor Fitzgerald reissued an “overweight” rating on shares of Theratechnologies in a research note on Friday, January 12th.
Read Our Latest Stock Report on TH
Theratechnologies Trading Up 12.6 %
Theratechnologies (TSE:TH – Get Free Report) last released its quarterly earnings results on Wednesday, February 21st. The company reported C($0.11) EPS for the quarter. The firm had revenue of C$31.93 million for the quarter. Theratechnologies had a negative net margin of 29.30% and a negative return on equity of 1,116.86%. On average, sell-side analysts forecast that Theratechnologies Inc. will post 0.0305882 EPS for the current fiscal year.
About Theratechnologies
Theratechnologies Inc, a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, a recombinant humanized monoclonal antibody, which is an injection for the treatment of multidrug resistant HIV-1 infected patients.
Featured Articles
- Five stocks we like better than Theratechnologies
- 3 Grocery Stocks That Are Proving They Are Still Essential
- 3 Value Stocks Too Small For Buffett’s Portfolio
- What Do S&P 500 Stocks Tell Investors About the Market?
- Foot Locker Builds Up Another Head of Steam; Gains Imminent
- EV Stocks and How to Profit from Them
- Disney Stock Catches 3 Upgrades In a Single Week
Receive News & Ratings for Theratechnologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Theratechnologies and related companies with MarketBeat.com's FREE daily email newsletter.